Dolce MD Provides Emsculpt Neo Treatment in Laguna Beach, CA, for Muscle Building and Fat Reduction

Laguna Beach, CA – Dolce MD offers emsculpt neo in Laguna Beach CA. The treatment uses a combination of high-intensity electromagnetic energy and radiofrequency. It targets fat reduction and muscle growth without the need for surgery or downtime. Emsculpt Neo is FDA-cleared and is used to treat multiple areas of the body, including the abdomen, […]

Con Edison to Report 2025 Earnings on February 19

Consolidated Edison, Inc. (Con Edison) (NYSE:ED) plans to report its 2025 earnings on February 19, 2026 after the market closes. Consolidated Edison, Inc. is a holding company that provides a wide range of energy-related products and services to its customers through the following subsidiaries: Consolidated Edison Company of New York, Inc., a regulated utility providing

Goodyear Names Managing Director, Americas & Chief Sales Officer, Americas Consumer

The Goodyear Tire & Rubber Company (NASDAQ: GT) today announced that David Cichocki will join Goodyear as Managing Director, Americas & Chief Sales Officer, Americas Consumer, effective?Jan. 19, reporting to?Mark Stewart, Chief Executive Officer and President.? As Chief Sales Officer, Americas Consumer, Cichocki will lead Goodyear’s Americas Consumer business, with a clear mandate to strengthen

MDU Resources to Webcast Year-End 2025 Earnings Conference Call

MDU Resources Group, Inc. (NYSE: MDU) will webcast its year-end 2025 earnings conference call at 2 p.m. ET Feb. 5. The company will release its year-end results before U.S. financial markets open that day. The webcast can be accessed at www.mdu.com under the “Investors” heading. Select “Events & Presentations,” and click “Year-End 2025 Earnings Conference

Hormel Foods Taps Domenic Borrelli as Executive Vice President of Retail, Bringing Extensive Category Leadership to Iconic Brand Portfolio

Hormel Foods Corporation (NYSE: HRL), a Fortune 500 global branded food company, today announced the appointment of Domenic Borrelli as executive vice president of Retail, effective February 23, 2026. In this role, Borrelli will oversee the Retail business unit, which includes many of the company’s most recognized consumer brands and represents one of its largest

NEUBERGER MUNICIPAL FUND ANNOUNCES MONTHLY DISTRIBUTION

Neuberger Municipal Fund Inc. (NYSE American: NBH) (the “Fund”) has announced a distribution declaration of $0.05417 per share of common stock. The distribution announced today is payable on February 17, 2026, has a record date of January 30, 2026, and has an ex-date of January 30, 2026. The Fund seeks to provide income that is

CMS Energy to Announce Year-End Results on February 5

CMS Energy announced today it will provide 2025 year-end results along with a business and financial outlook at 10:00 a.m. EST on Thursday, February 5, 2026. A webcast of the presentation will be available on CMS Energy’s website, cmsenergy.com. An audio replay will be available approximately three hours after the webcast and will be archived

The Wendy’s Company to Report Fourth Quarter and Full Year 2025 Results on February 13

The Wendy’s Company (Nasdaq: WEN) will release its fourth quarter and full year 2025 results and share its 2026 financial outlook before the market opens on Friday, February 13. The Company will host a conference call that same day at 8:30 a.m. ET, with a simultaneous webcast accessible from the Company’s Investor Relations website at

Woodward to Wind Down China On-Highway Natural Gas Truck Business, Enhancing Strategic Focus

(NASDAQ:WWD), FORT COLLINS, Colo., Jan. 15, 2026 (GLOBE NEWSWIRE) — Woodward, Inc. (NASDAQ: WWD) today announced plans to wind down its on-highway natural gas truck business in China (China OH) as part of its strategy to sharpen the focus of its Industrial segment and optimize Woodward's product portfolio. “Winding down the China OH business is

Serina Therapeutics Receives NYSE Deficiency Notification Regarding Shareholders’ Equity

(NYSE MKT:SER), HUNTSVILLE, Jan. 15, 2026 (GLOBE NEWSWIRE) — Serina Therapeutics, Inc. (“Serina” or the “Company”) (NYSE American: SER), a clinical-stage biotechnology company advancing its lead Investigational New Drug (“IND”) candidate, SER-252, for advanced Parkinson's disease, enabled by its proprietary POZ PlatformTM drug optimization technology, received a notice from the New York Stock Exchange (“NYSE”)

Scroll to Top